Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Prepaid Assets: 2021-2025

Historic Prepaid Assets for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $35.4 million.

  • LifeStance Health's Prepaid Assets rose 3489.18% to $35.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.4 million, marking a year-over-year increase of 3489.18%. This contributed to the annual value of $26.1 million for FY2024, which is 2155.61% up from last year.
  • As of Q3 2025, LifeStance Health's Prepaid Assets stood at $35.4 million, which was up 3489.18% from $40.4 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Prepaid Assets registered a high of $71.9 million during Q3 2023, and its lowest value of $18.7 million during Q1 2024.
  • Its 5-year average for Prepaid Assets is $36.0 million, with a median of $32.7 million in 2025.
  • As far as peak fluctuations go, LifeStance Health's Prepaid Assets skyrocketed by 7213.35% in 2022, and later plummeted by 6351.4% in 2024.
  • Quarter analysis of 5 years shows LifeStance Health's Prepaid Assets stood at $42.4 million in 2021, then plummeted by 44.04% to $23.7 million in 2022, then fell by 9.4% to $21.5 million in 2023, then grew by 21.56% to $26.1 million in 2024, then surged by 35.44% to $35.4 million in 2025.
  • Its Prepaid Assets was $35.4 million in Q3 2025, compared to $40.4 million in Q2 2025 and $29.9 million in Q1 2025.